 | • レポートコード：MRC2-11QY04095 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は中咽頭がん診断・治療のグローバル市場について調査・分析したレポートです。種類別（内視鏡検査、生検、画像）市場規模、用途別（病院、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別中咽頭がん診断・治療の競争状況、市場シェア ・世界の中咽頭がん診断・治療市場：種類別市場規模 2015年-2020年（内視鏡検査、生検、画像） ・世界の中咽頭がん診断・治療市場：種類別市場規模予測 2021年-2026年（内視鏡検査、生検、画像） ・世界の中咽頭がん診断・治療市場：用途別市場規模 2015年-2020年（病院、外来手術センター） ・世界の中咽頭がん診断・治療市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター） ・北米の中咽頭がん診断・治療市場分析：米国、カナダ ・ヨーロッパの中咽頭がん診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの中咽頭がん診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の中咽頭がん診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの中咽頭がん診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、GE Healthcare、Synta Pharmaceuticals、VLPbio、Novartis、Immunovaccine、Inovio Pharmaceuticals、AB Science、Bayer、Bristol-Myers Squibb、Boston Biomedical、AstraZeneca ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Oropharyngeal cancer is a malignant tumour that starts in the cells of the oropharynx.
Rising prevalence of oropharyngeal cancer has been the major factor driving the market growth. Additionally, increasing geriatric population and rising oropharyngeal cancer associated with them is another factor driving the market growth. Moreover, growing number of smokers and alcohol consumers which are most prone to this cancer has been a major factor for the market growth.
Market Analysis and Insights: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
The global Oropharyngeal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Oropharyngeal Cancer Diagnosis and Therapeutics Scope and Market Size
Oropharyngeal Cancer Diagnosis and Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oropharyngeal Cancer Diagnosis and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
GE Healthcare
Synta Pharmaceuticals
VLPbio
Novartis
Immunovaccine
Inovio Pharmaceuticals
AB Science
Bayer
Bristol-Myers Squibb
Boston Biomedical
AstraZeneca
Market segment by Type, the product can be split into
Endoscopy
Biopsy
Imaging
Market segment by Application, split into
Hospitals
Ambulatory surgery centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oropharyngeal Cancer Diagnosis and Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Endoscopy
1.4.3 Biopsy
1.4.4 Imaging
1.5 Market by Application
1.5.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory surgery centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Perspective (2015-2026)
2.2 Global Oropharyngeal Cancer Diagnosis and Therapeutics Growth Trends by Regions
2.2.1 Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Oropharyngeal Cancer Diagnosis and Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Oropharyngeal Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Oropharyngeal Cancer Diagnosis and Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Oropharyngeal Cancer Diagnosis and Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Oropharyngeal Cancer Diagnosis and Therapeutics Players by Market Size
3.1.1 Global Top Oropharyngeal Cancer Diagnosis and Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Concentration Ratio
3.2.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in 2019
3.3 Oropharyngeal Cancer Diagnosis and Therapeutics Key Players Head office and Area Served
3.4 Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Product Solution and Service
3.5 Date of Enter into Oropharyngeal Cancer Diagnosis and Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Oropharyngeal Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
5.2 Global Oropharyngeal Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
6.2 Oropharyngeal Cancer Diagnosis and Therapeutics Key Players in North America (2019-2020)
6.3 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
6.4 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
7.2 Oropharyngeal Cancer Diagnosis and Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
7.4 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
8.2 Oropharyngeal Cancer Diagnosis and Therapeutics Key Players in China (2019-2020)
8.3 China Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
8.4 China Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
9.2 Oropharyngeal Cancer Diagnosis and Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
9.4 Japan Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
10.2 Oropharyngeal Cancer Diagnosis and Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
11.2 Oropharyngeal Cancer Diagnosis and Therapeutics Key Players in India (2019-2020)
11.3 India Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
11.4 India Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (2015-2020)
12.2 Oropharyngeal Cancer Diagnosis and Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
13.1.4 Merck Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020))
13.1.5 Merck Recent Development
13.2 GE Healthcare
13.2.1 GE Healthcare Company Details
13.2.2 GE Healthcare Business Overview
13.2.3 GE Healthcare Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
13.2.4 GE Healthcare Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.2.5 GE Healthcare Recent Development
13.3 Synta Pharmaceuticals
13.3.1 Synta Pharmaceuticals Company Details
13.3.2 Synta Pharmaceuticals Business Overview
13.3.3 Synta Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
13.3.4 Synta Pharmaceuticals Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.3.5 Synta Pharmaceuticals Recent Development
13.4 VLPbio
13.4.1 VLPbio Company Details
13.4.2 VLPbio Business Overview
13.4.3 VLPbio Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
13.4.4 VLPbio Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.4.5 VLPbio Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
13.5.4 Novartis Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Immunovaccine
13.6.1 Immunovaccine Company Details
13.6.2 Immunovaccine Business Overview
13.6.3 Immunovaccine Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
13.6.4 Immunovaccine Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.6.5 Immunovaccine Recent Development
13.7 Inovio Pharmaceuticals
13.7.1 Inovio Pharmaceuticals Company Details
13.7.2 Inovio Pharmaceuticals Business Overview
13.7.3 Inovio Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
13.7.4 Inovio Pharmaceuticals Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.7.5 Inovio Pharmaceuticals Recent Development
13.8 AB Science
13.8.1 AB Science Company Details
13.8.2 AB Science Business Overview
13.8.3 AB Science Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
13.8.4 AB Science Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.8.5 AB Science Recent Development
13.9 Bayer
13.9.1 Bayer Company Details
13.9.2 Bayer Business Overview
13.9.3 Bayer Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
13.9.4 Bayer Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.9.5 Bayer Recent Development
13.10 Bristol-Myers Squibb
13.10.1 Bristol-Myers Squibb Company Details
13.10.2 Bristol-Myers Squibb Business Overview
13.10.3 Bristol-Myers Squibb Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
13.10.4 Bristol-Myers Squibb Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020)
13.10.5 Bristol-Myers Squibb Recent Development
13.11 Boston Biomedical
10.11.1 Boston Biomedical Company Details
10.11.2 Boston Biomedical Business Overview
10.11.3 Boston Biomedical Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
10.11.4 Boston Biomedical Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020)
10.11.5 Boston Biomedical Recent Development
13.12 AstraZeneca
10.12.1 AstraZeneca Company Details
10.12.2 AstraZeneca Business Overview
10.12.3 AstraZeneca Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
10.12.4 AstraZeneca Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020)
10.12.5 AstraZeneca Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Oropharyngeal Cancer Diagnosis and Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Oropharyngeal Cancer Diagnosis and Therapeutics Revenue
Table 3. Ranking of Global Top Oropharyngeal Cancer Diagnosis and Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Endoscopy
Table 6. Key Players of Biopsy
Table 7. Key Players of Imaging
Table 8. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Oropharyngeal Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Oropharyngeal Cancer Diagnosis and Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Oropharyngeal Cancer Diagnosis and Therapeutics Players
Table 19. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Oropharyngeal Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics as of 2019)
Table 22. Global Oropharyngeal Cancer Diagnosis and Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Product Solution and Service
Table 25. Date of Enter into Oropharyngeal Cancer Diagnosis and Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 35. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 37. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 41. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 47. China Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 49. China Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 53. Japan Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 65. India Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 67. India Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 71. Central & South America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Product
Table 78. Merck Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 79. Merck Recent Development
Table 80. GE Healthcare Company Details
Table 81. GE Healthcare Business Overview
Table 82. GE Healthcare Product
Table 83. GE Healthcare Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 84. GE Healthcare Recent Development
Table 85. Synta Pharmaceuticals Company Details
Table 86. Synta Pharmaceuticals Business Overview
Table 87. Synta Pharmaceuticals Product
Table 88. Synta Pharmaceuticals Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 89. Synta Pharmaceuticals Recent Development
Table 90. VLPbio Company Details
Table 91. VLPbio Business Overview
Table 92. VLPbio Product
Table 93. VLPbio Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 94. VLPbio Recent Development
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Product
Table 98. Novartis Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 99. Novartis Recent Development
Table 100. Immunovaccine Company Details
Table 101. Immunovaccine Business Overview
Table 102. Immunovaccine Product
Table 103. Immunovaccine Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 104. Immunovaccine Recent Development
Table 105. Inovio Pharmaceuticals Company Details
Table 106. Inovio Pharmaceuticals Business Overview
Table 107. Inovio Pharmaceuticals Product
Table 108. Inovio Pharmaceuticals Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 109. Inovio Pharmaceuticals Recent Development
Table 110. AB Science Business Overview
Table 111. AB Science Product
Table 112. AB Science Company Details
Table 113. AB Science Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 114. AB Science Recent Development
Table 115. Bayer Company Details
Table 116. Bayer Business Overview
Table 117. Bayer Product
Table 118. Bayer Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 119. Bayer Recent Development
Table 120. Bristol-Myers Squibb Company Details
Table 121. Bristol-Myers Squibb Business Overview
Table 122. Bristol-Myers Squibb Product
Table 123. Bristol-Myers Squibb Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 124. Bristol-Myers Squibb Recent Development
Table 125. Boston Biomedical Company Details
Table 126. Boston Biomedical Business Overview
Table 127. Boston Biomedical Product
Table 128. Boston Biomedical Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 129. Boston Biomedical Recent Development
Table 130. AstraZeneca Company Details
Table 131. AstraZeneca Business Overview
Table 132. AstraZeneca Product
Table 133. AstraZeneca Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 134. AstraZeneca Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Endoscopy Features
Figure 3. Biopsy Features
Figure 4. Imaging Features
Figure 5. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory surgery centers Case Studies
Figure 8. Oropharyngeal Cancer Diagnosis and Therapeutics Report Years Considered
Figure 9. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Players in 2019
Figure 14. Global Top Oropharyngeal Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in 2019
Figure 16. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
大腸がん診断・治療の世界市場（～2026年） Colorectal cancer is the development of cancer from the colonor rectum. The main market drivers are increasing cancer prevention initiatives, technological advancements in radiology and chemotherapy, and increasing incidence and prevalence of colorectal cancer. Market Analysis and Insights: Global C…- 骨肉腫診断・治療の世界市場（～2026年） Bone cancer is a malignant tumor that arises from the cells that make up the bones of the body. Robust healthcare expenditure in developed countries, genetic disorder, and development of stem cell transplant technology are some of the major factors that drive the growth of the market. Rising geriatr…
- 肺がん診断・治療の世界市場（～2026年） Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the …
- 皮膚がん診断・治療の世界市場（～2026年） Skin cancer is the uncontrolled development of anomalous skin cells. The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer. Market Analysis and Insights: Global Skin Cancer Diagnosis and Therapeutics Market Th…
- 前立腺がん診断・治療の世界市場（～2026年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. The market is growing impressively due to rise in incidence and prevalence rate of prostate cancer, robust R&D exploration and rising investment in grants and investment across the globe. Market An…